Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Epiroc A | EPIA | 22. nov 2024 | 196.00 | +0.13 |
Epiroc B | EPIB | 22. nov 2024 | 176.30 | +0.06 |
Episurf Medical B | EPISB | 22. nov 2024 | 0.14 | -3.98 |
EQL Pharma | EQL | 22. nov 2024 | 66.40 | 0.00 |
EQT | EQT | 22. nov 2024 | 307.10 | +2.57 |
Ericsson A | ERICA | 22. nov 2024 | 88.90 | +1.48 |
Ericsson B | ERICB | 22. nov 2024 | 89.16 | +1.36 |
ES Energy Save Holding | ESGRB | 22. nov 2024 | 29.45 | +1.38 |
Essity A | ESSITYA | 22. nov 2024 | 303.00 | +1.51 |
Essity B | ESSITYB | 22. nov 2024 | 302.20 | +1.10 |
Eurobattery Minerals | BAT | 22. nov 2024 | 0.11 | -1.82 |
European Institute of Science B | EURIB | 22. nov 2024 | 2.30 | 0.00 |
Everysport Group AB | EVERY | 22. nov 2024 | 17.85 | +2.59 |
Evolear AB | EVOL | 22. nov 2024 | 0.51 | +2.00 |
Evolution | EVO | 22. nov 2024 | 983.60 | +0.68 |
Ework Group AB. | EWRK | 22. nov 2024 | 139.60 | +0.14 |
Exalt | EXALT | 22. nov 2024 | 0.44 | +4.78 |
ExpreS2ion Biotech Holding | EXPRS2 | 22. nov 2024 | 19.24 | -3.32 |
Exsitec | EXS | 22. nov 2024 | 141.50 | -1.74 |
Eyeonid Group | EOID | 22. nov 2024 | 18.62 | +8.00 |
Fabege | FABG | 22. nov 2024 | 83.40 | +2.84 |
Fable Media Group AB | FABLE | 22. nov 2024 | 7.00 | +1.45 |
Fagerhult Group AB | FAG | 22. nov 2024 | 58.20 | -0.68 |
Fantasma Games | FAGA | 22. nov 2024 | 57.50 | 0.00 |
Fasadgruppen | FG | 22. nov 2024 | 40.20 | -1.59 |
Fastator | FASTAT | 22. nov 2024 | 1.17 | +0.17 |
Fastpartner A | FPARA | 22. nov 2024 | 66.30 | +2.00 |
Fastpartner D | FPARD | 22. nov 2024 | 72.30 | +1.97 |
Fenix Outdoor B | FOIB | 22. nov 2024 | 600.00 | +0.50 |
Ferroamp AB | FERRO | 22. nov 2024 | 4.04 | +6.32 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.